ONCY Latest Press Releases

-- April 6, 2026 --

Oncolytics Biotech Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer Globe Newswire 9:00 AM

-- April 1, 2026 --

Oncolytics Biotech Completes Domicile Change to the United States Globe Newswire 9:00 AM

-- March 19, 2026 --

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology Globe Newswire 11:00 AM

Oncolytics Biotech to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026 Globe Newswire 9:01 AM

-- March 2, 2026 --

Oncolytics Biotech Launches Randomized Colorectal Cancer Study Globe Newswire 9:00 AM

-- February 24, 2026 --

Oncolytics Biotech to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer Globe Newswire 9:00 AM

-- February 17, 2026 --

Registration Momentum Builds Across the Oncology Pipeline Globe Newswire 10:48 AM

-- February 5, 2026 --

The $71 Billion Cancer Shift: Why The FDA Is Speeding Up Globe Newswire 9:26 AM

-- February 4, 2026 --

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer Globe Newswire 8:50 AM

-- January 26, 2026 --

THE RESILIENCE DOCTRINE: 5 Assets Securing the 2026 Sovereign Stack Globe Newswire 10:13 AM

-- January 15, 2026 --

Oncolytics Biotech Announces Results of Special Meeting of Shareholders Globe Newswire 4:01 PM

-- January 14, 2026 --

The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era Globe Newswire 10:40 AM

THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points Globe Newswire 10:15 AM

Oncolytics Biotech Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics Globe Newswire 9:00 AM

-- January 12, 2026 --

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff Globe Newswire 10:14 AM

Oncolytics Biotech Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer Globe Newswire 9:00 AM

-- January 9, 2026 --

Oncolytics Biotech Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada Globe Newswire 9:00 AM

-- January 8, 2026 --

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech Globe Newswire 12:08 PM

Oncolytics Biotech Provides Update on Intellectual Property Strategy and Patent Filings Business Wire 9:00 AM

-- January 7, 2026 --

THE CHOKE POINT: 5 Assets That Control the Bottleneck Globe Newswire 12:15 PM

Oncolytics Biotech Expands Its Gastrointestinal Tumor Scientific Advisory Board with the Addition of Dr. Eileen O'Reilly, Dr. Neil Segal, and Dr. Van Morris Business Wire 9:00 AM

-- December 16, 2025 --

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards Globe Newswire 12:18 PM

Oncolytics Biotech Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer Business Wire 9:00 AM

-- December 15, 2025 --

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis Globe Newswire 10:54 AM

-- December 12, 2025 --

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PRNewswire 10:48 AM

GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era Globe Newswire 10:31 AM

-- December 9, 2025 --

Oncolytics Biotech Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada Business Wire 6:00 PM

-- December 6, 2025 --

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality Globe Newswire 1:51 PM

-- December 3, 2025 --

UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality Globe Newswire 3:31 PM

The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality Globe Newswire 12:51 PM

-- November 20, 2025 --

Oncolytics Biotech Provides Update on Special Meeting of Shareholders Business Wire 4:05 PM

-- November 19, 2025 --

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B Globe Newswire 9:45 AM

Oncolytics Biotech Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer Business Wire 9:00 AM